Profiel
Jason Sheltzer is the founder of Meliora Therapeutics, Inc. which was founded in 2021.
Actieve functies van Jason Sheltzer
| Bedrijven | Functie | Begin |
|---|---|---|
Meliora Therapeutics, Inc.
 Meliora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Meliora Therapeutics, Inc. is an American company that is revolutionizing cancer drug development by utilizing genomics and advanced computational methods as key components of their product development process. The company is based in California. The company has created "molecular fingerprints" for thousands of compounds to build an inference engine that identifies risk-adjusted small molecule compound and target mechanism of action (moa) pairs. This unique discovery engine has the potential for high clinical success. Meliora Therapeutics was founded in 2021 by Jason Sheltzer, Joan Smith, and David Li. David Li has been the CEO since 2021. | Oprichter | 01-09-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Meliora Therapeutics, Inc.
Meliora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Meliora Therapeutics, Inc. is an American company that is revolutionizing cancer drug development by utilizing genomics and advanced computational methods as key components of their product development process. The company is based in California. The company has created "molecular fingerprints" for thousands of compounds to build an inference engine that identifies risk-adjusted small molecule compound and target mechanism of action (moa) pairs. This unique discovery engine has the potential for high clinical success. Meliora Therapeutics was founded in 2021 by Jason Sheltzer, Joan Smith, and David Li. David Li has been the CEO since 2021. | Commercial Services |
